PubMed · 10786183
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
R G Ritter. 1999. Advanced adhesive technology.. https://pubmed.ncbi.nlm.nih.gov/10786183/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
Recently, tablets inscribed with the Mitsubishi 3-diamond logo, and sold as 3,4-methylenedioxymethamphetamine (MDMA), were found to contain p-methoxymethamphetamine (PMMA), a compound with MDMA-like effects. Shortly after this first submission, similarly inscribed tablets were encountered containing both PMMA and p-methoxyamphetamine (PMA). This second tablet composition has been implicated in several recent deaths in the US. Because two other positions are available for mono-methoxy substitution on the phenyl ring, it is essential that the correct identification be made for these compounds. Analytical data are supplied to enable differentiation of these ring isomers as well as the ketones that serve as their precursors.
Imexon is a cyanoaziridine derivative that has antitumor activity in multiple myeloma. Previous studies have shown that imexon induces oxidative stress and apoptosis in the RPMI 8226 myeloma cell line. This study reports that imexon has cytotoxic activity in other malignant cell lines including NCI-H929 myeloma cells and NB-4 acute promyelocytic leukemia cells, whereas normal lymphocytes and U266 myeloma cells are substantially less sensitive. Flow cytometric experiments have shown that imexon treatment is associated with the formation of reactive oxygen species (ROS) and the loss of mitochondrial membrane potential (Deltapsi(m)) in imexon-sensitive myeloma cell lines and NB-4 cells. In contrast, reduction of Deltapsi(m) and increased levels of ROS were not observed in imexon-resistant U266 cells. Treatment of imexon-sensitive RPMI 8226 cells with the antioxidant N-acetyl-L-cysteine (NAC) protects cells against these effects of imexon. Mitochondrial swelling was observed by electron microscopy in RPMI 8226 myeloma cells treated with 180 microM imexon as early as 4 hours. Damage to mitochondrial DNA was detected by a semiquantitative polymerase chain reaction assay in imexon-treated RPMI 8226 cells; however, nuclear DNA was not affected. Finally, partial protection of RPMI 8226 cells against the imexon effects was achieved by treatment with theonyltrifluoroacetone, an inhibitor of superoxide production at mitochondrial complex II. These changes are consistent with mitochondrial oxidation and apoptotic signaling as mediators of the growth inhibitory effects of imexon. Interestingly, oxidative damage and decrease of Deltapsi(m) induced by imexon highly correlates with sensitivity to imexon in several myeloma cell lines and an acute promyelocytic leukemia cell line. (Blood. 2001;97:3544-3551)
Standard apparent reduction potentials are important because they give a more global view of the driving forces for redox reactions than do the standard transformed Gibbs energies of formation of the reactants. This paper emphasizes the effects of pH on biochemical half reactions in the range pH 5 to 9, but it also shows the effect of ionic strength. These effects can be calculated if the pKs of acid groups in the reactants are known in the range pH 4 to 10. Raising the pH decreases the standard apparent reduction potentials of half reactions when it has an effect, and the slope is proportional to minus one times the ratio of the change in binding of hydrogen ions in the half reaction to the number of electrons transferred. These effects are discussed for 19 biochemical reactions. This effect is most striking for the nitrogenase reaction, where the apparent equilibrium constant is proportional to 10(-10 pH) and is unfavorable for nitrogen fixation above pH 8.